Hüseyin Gülen
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hüseyin Gülen.
Pediatric Hematology and Oncology | 2006
Hüseyin Gülen; Funda Tüzün; Yüce Ayhan; Ayşe Erbay; Ercan Öztürk; Seyhan Inan; Canan Vergin
Safety of blood and blood products is a major problem all over the world. Screening for the markers of infectious diseases is an incomplete solution. One of the most important steps in improving the safety of blood and blood products is donor selection. In this study, causes of donor deferral were evaluated retrospectively in the blood center of a childrens hospital. Analysis of the deferrals showed that the most commonly defined causes were recent sexual exposure in high-risk activity, recent ingestion of medication, low hemoglobin level, abnormal blood pressure, being underweight, tattoos, piercing or acupuncture in the preceding 6 months, recent history of infection and presenting for a subsequent donation too soon, elevation of transaminases, presence of the markers of the infectious diseases.
Leukemia & Lymphoma | 2004
Ozgur Cogulu; Buket Kosova; Emin Karaca; Cumhur Gunduz; Ferda Ozkinay; Serap Aksoylar; Hüseyin Gülen; Mehmet Kantar; Haldun Öniz; Deniz Yilmaz Karapinar; Nazan Çetingül; Ayşe Erbay; Canan Vergin; Cihangir Ozkinay
Human telomerase reverse transcriptase (hTERT) is the catalytic component of telomerase enzyme and has been shown to be associated with telomerase activity (TA). Although many studies in adult leukemia have established the importance of TA, very few have been reported in the children. In this study hTERT levels in childhood leukemia was evaluated and compared with the prognostic factors described before. The LightCycler instrument was used (online real-time PCR) for the quantification of hTERT in peripheral blood and bone marrow in 23 cases with acute lymphoblastic leukemia (ALL) and in 8 cases with acute myeloblastic leukemia (AML). Ten cases with normal peripheral blood (PB) and bone marrow (BM) were selected as control group. Cytogenetic analyses were available in 21 patients with leukemia. In all cases with acute leukemia and in control group, peripheral blood (PB) hTERT levels correlated significantly with bone marrow (BM) hTERT levels. Before treatment, patients with ALL had significantly higher hTERT levels than that of AML patients and control cases. Among patients with ALL, higher hTERT levels were observed in patients with pre-B leukemia, followed by B cell and T cell leukemia patients. Initially increased hTERT levels decreased to the nearly normal levels during remission in cases with ALL. No correlation was observed between the initial hTERT levels and the known prognostic factors except cytogenetic findings. Higher hTERT levels were detected in patients having karyotypic abnormalities which indicate poor prognosis. hTERT levels are significantly high in childhood ALL with the highest level of pre-B cell leukemia before treatment. Those high levels of hTERT decrease to almost normal levels in remission. hTERT levels might be useful in monitoring of leukemia in children.
Turkish journal of haematology : official journal of Turkish Society of Haematology | 2011
Elif Kazancı; Hüseyin Gülen; Ayşe Erbay; Canan Vergin
We report two male cases (4- and 5-years-old) of intrathecal methotrexate overdose. The two boys with acute lymphoblastic leukemia were to receive intrathecal injection of methotrexate. Instead of the prescribed 12 mg, they both received a dose of 120 mg. The initial cerebrospinal fluid samples showed methotrexate concentration of 2.24x10-2M in case 1 and 1.32x10-2M in case 2. The cases were successfully treated with cerebrospinal fluid (CSF) exchange and intravenous folinic acid rescue. The favorable outcome in our cases suggests that CSF exchange is safe and that folinic acid rescue may be adequate to prevent sequelae in patients subjected to intrathecal MTX overdoses up to 120 mg. We propose CSF exchange and intravenous folinic acid as the mainstay of treatment. In addition to the staffs failure to check the drug label carefully, the marked resemblance of the two dose preparations of MTX may have been contributory.
Human Biology | 2005
Mustafa Tekin; Duygu Akcayoz; Canan Ucar; Hüseyin Gülen; Nejat Akar
The 657del5 mutation of the NBS1 gene has been demonstrated in most patients with Nijmegen breakage syndrome (NBS). We identified four Turkish families in which probands were diagnosed as having NBS and found to be homozygous for the 657del5 mutation. The 657del5 allele in the four Turkish families had a single origin.
Archive | 2005
Hüseyin Gülen; Elif Kazancı; Demir Gökçer Özek; Selcan Yamaci; Behcet Uz
Turkish journal of haematology : official journal of Turkish Society of Haematology | 2006
Gülersu Irken; Hale Ören; Haldun Öniz; Nazan Çetingül; Canan Vergin; Berna Atabay; Hüseyin Gülen; Meral Türker; Mehmet Kantar; Yılmaz Ş
Annals of Tropical Paediatrics | 2004
Ferah Genel; A. Cevik; A. Erbay; Hüseyin Gülen; N. Uran; Canan Vergin
Archive | 2011
Hüseyin Gülen; Canan Vergin
Turkiye Klinikleri Journal of Pediatrics | 2010
Hüseyin Gülen
Turkiye Klinikleri Journal of Pediatrics | 2009
Saniye Gülle; Hüseyin Gülen; Hasan Ağin; Ferah Genel; Suna Asilsoy; Canan Vergin; Safiye Aktaş